Rise Nano Optics Ltd. · CSE:EYE

Rise Nano Optics — Investor Presentation (July 2025)

20 slides from Rise Nano Optics's investor presentation, July 2025

  1. Slide 1: Redefining Light for Healthy Vision

    Redefining Light for Healthy Vision A breakthrough in preventative eye care. Investor Presentation – July 2025 ÆOS

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Information This document contains forward looking statements, including Future Oriented Financial Information (“FOFI”) that relate to our current expectations and views of future events. Certain information contained herein and certain made are forward-looking and relate

  3. Slide 3: RISE Investment Highlights

    RISE Investment Highlights Addressable Market : $160Bn eyewear market. More than 560M diabetics worldwide already suffer from acute eye disease. 30% of adults spend more than 9 hours a day on an electronic device. Proprietary, patented EYEGUARD innovative technology — a breakthrough in preventative

  4. Slide 4: Harmful Light Causes Eye Diseases

    The leading causes of blindness and low vision in the United States are primarily age-related eye Harmful Light Causes diseases (CDC) Exposure to harmful UV and blue light is the Eye Diseases leading cause of the development of eye diseases such as cataracts, retinopathy (DR), macular degeneration (

  5. Slide 5: You Need Protection Against Harmful Light

    You Need Protection Against Harmful Light • On average, adults spend more than 7 hours a day in front of phones, tablets, and computers • Children and adults alike spend more than 7-10 hours exposed to fluorescent light, led, and filament light • The developing eyes of the young are vulnerable to ha

  6. Slide 6: Harmful Light is High Energy – Biologically Damaging

    Harmful Light is High Energy – Biologically Damaging Everywhere Fluorescent Filament Tablet LED Sun Harmful wavelengths are present in the natural and 75,000 created environment. 50,000 INTENSITY (A.U.) 25,000 0 INVESTOR DECK JAN'23 WAVELENGTH (NM)

  7. Slide 7: Our Scientific Breakthrough

    Our Scientific Breakthrough The role of protection Without RISE Filter Harmful light leads to complications on a microscopic level in the retinal cells of an albino rat. With RISE Filter RED: Appearance of the GFAP in Muller Cells BLUE: Thickness of Photoreceptor Layer

  8. Slide 8: RISE: The Best Solution Against Harmful Light

    RISE: The Best Solution Guarantees 100% protection from UV rays Against Harmful Light Reduces the pressure exerted on the eye thereby increasing the level of comfort At the core of its innovation is the patented EYEGUARD technology — a breakthrough in preventative eye care that merges science, welln

  9. Slide 9: The RISE Difference

    The RISE Difference Light Filtered The only lens to filter more than The only lens with nanoparticles 90% of harmful extended blue- diffused into the lenses for light wavelengths quicker transition and protection (400-600nm) from harmful light Light Reflected The lenses are Made with backed by metal

  10. Slide 10: Crystal Clear Vision, Unmatched Style

    Crystal Clear Vision, Benefit to client Fashionable Non-stigmatizing colour Unmatched Style Benefit to optician Replace All Specialty Lenses With One Less inventory to maintain 450nm 500nm 540nm 480nm • Night Blindness • Macular • Macular • Macular • Macular Degeneration Degeneration Degeneration De

  11. Slide 11: Innovative Nano Technology

    Innovative Nano Technology • Nano particles of different sizes and dimensions can absorb different wavelengths • Rise mix of these nano particles absorbs 90% of every wavelength between 400 and 600nm Traditional coating Nanotechnology

  12. Slide 12: Total Addressable Market

    Total Addressable Market $160B $160B Mass Market Mass Market $XB Other Adults $1.25 Billion $6B $XB 40+ AMD Adults Diabetic Lens Market Adults $6 Billion Replaces All Ugly Specialty Lenses More than half of Americans over the age of 40, 24 Million, $1.25B suffer from cataracts, AMD and myopia Diabet

  13. Slide 13: 75% of the adult population wear corrective lenses

    Increasing usage of phones, tablets, and PCs leads to increasing adoption of lenses "75% of the adult An estimated 537 million adults are living with diabetes - 1 in 10. This number to RISE to 784 million within 2 decades population wear The number of people living with macular corrective lenses" de

  14. Slide 14: Business Model

    Business Model Order: An order is made at the optician and sent to the manufacturer. Manufacturing cost to RISE $ 5 per pair of lenses. ✓ Competitive Contract With Manufacturers ✓ Low Per Unit Cost ✓ High Per Unit Margin Retail Sales If you havePrice: plenty of ways The suggested price to focus to m

  15. Slide 15: Go To Market Strategy Penetrating Key Markets

    Go To Market Strategy Q1/2023 Penetrating Key Markets Strategic Agreement with leading Israeli Lens Manufacturer Q2/2024 Launch of RISE in Israel High concentration of eye damage from disease Israel High levels of harmful light exposure from lifestyle America High levels of exposure to natural light

  16. Slide 16: Financial Summary

    Financial Summary Revenues USD 2025 2026 2027 2028 2029 Total Total Revenues 1,117,513 5,900,698 15,984,377 24,735,410 34,123,499 81,868,772 COGS 288,019 1,520,799 4,614,047 7,140,118 9,850,082 23,414,015 Gross Profit 829,494 4,379,900 11,370,330 17,595,291 24,273,417 58,454,757 Gross Profit Margin

  17. Slide 17: Strong Patent Protection

    Strong Patent Protection Patent Status Country & Date Medical patent (licensed from the Technion USA & India Institute of Technology of Israel) No. 8833937 (USA) 16-Sep-2014 Method and a system for protection of No. 316658 (INDIA) 23-Jul-2019 retina from a light induced damage : GRANTED USA Products

  18. Slide 18: Use of Proceeds Go Public Transaction

    Use of Proceeds Go Public Transaction RTO Financing Round: ~US$4.0M M&S Global - $2.3M Production & Tooling & Commercialization - $800K IP&LEGAL - $200K OPEX - $500 G&A - $200K

  19. Slide 19: RISE Leadership

    RISE Leadership Backed by a team of industry leaders and experts in the medical field with proven track record of delivery and success DR. INAS SAID PROF. NAIM SHEHADEH DR. Awad Shalabny PROF. IDO PERLMAN GABI KABAZO Founder M.D. – Advisory Chief Technology Ph.D. – Advisory Chief Financial & CEO Boa

  20. Slide 20: Thank You!

    RISE lenses are unlike anything I’ve encountered in my years of experience. They not only provide exceptional comfort and ease on the eyes, but also deliver sharper vision, enhanced contrast, and a vivid richness of color. What truly amazed me was learning that these benefits come hand-in- hand with

RISE Nano Optics — Investor Presentation (July 2025) on 6ix